BlackRock’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
291,957
-2,039,092
| -87% | -$2.37M | ﹤0.01% | 4460 |
|
|
2025
Q1 | $2.56M | Sell |
2,331,049
-40,998
| -2% | -$45.1K | ﹤0.01% | 3870 |
|
|
2024
Q4 | $4.08M | Buy |
2,372,047
+40,517
| +2% | +$69.7K | ﹤0.01% | 3761 |
|
|
2024
Q3 | $5.78M | Buy |
2,331,530
+172,869
| +8% | +$429K | ﹤0.01% | 3594 |
|
|
2024
Q2 | $5.22M | Buy |
2,158,661
+1,968,964
| +1,038% | +$4.76M | ﹤0.01% | 3619 |
|
|
2024
Q1 | $768K | Sell |
189,697
-58,398
| -24% | -$237K | ﹤0.01% | 4213 |
|
|
2023
Q4 | $953K | Sell |
248,095
-335,319
| -57% | -$1.29M | ﹤0.01% | 4201 |
|
|
2023
Q3 | $2.42M | Buy |
583,414
+100,090
| +21% | +$415K | ﹤0.01% | 3861 |
|
|
2023
Q2 | $2.32M | Sell |
483,324
-188,307
| -28% | -$906K | ﹤0.01% | 3906 |
|
|
2023
Q1 | $2.73M | Sell |
671,631
-473,056
| -41% | -$1.92M | ﹤0.01% | 3828 |
|
|
2022
Q4 | $6.18M | Buy |
1,144,687
+29,660
| +3% | +$160K | ﹤0.01% | 3562 |
|
|
2022
Q3 | $11.2M | Sell |
1,115,027
-1,578,284
| -59% | -$15.8M | ﹤0.01% | 3308 |
|
|
2022
Q2 | $12.7M | Sell |
2,693,311
-1,138,010
| -30% | -$5.35M | ﹤0.01% | 3310 |
|
|
2022
Q1 | $15M | Buy |
3,831,321
+721,651
| +23% | +$2.82M | ﹤0.01% | 3282 |
|
|
2021
Q4 | $21M | Buy |
3,109,670
+240,879
| +8% | +$1.63M | ﹤0.01% | 3185 |
|
|
2021
Q3 | $42.6M | Buy |
+2,868,791
| New | +$42.6M | ﹤0.01% | 2734 |
|